170635 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7) Phosphotransferases in general
Use of sarcoplasmic CA-ATPase type 2 protein for diagnosing and treating learning or mental disorders
#302COMBINATION METHODS OF DIAGNOSING CANCER IN A PATIENT
#303DETERMINING SENSITIVITY OF CELLS TO B-RAF INHIBITOR TREATMENT BY DETECTING KRAS MUTATION AND RTK EXPRESSION LEVELS
#304Kit for detecting and measuring element tagged kinases and phosphatases by inductively coupled plasma mass spectrometry
#305RAF DIMERS AND USES THEREOF
#306Whole blood assay for measuring AMPK activation
#307Modular point-of-care devices, systems, and uses thereof
#308AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy
#309RAF gene fusions
#310METHODS AND KITS FOR DETECTING PROSTATE CANCER BIOMARKERS
#311Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#312Diagnosis and treatment of breast cancer
#313Compositions and methods for detecting mutations in JAK2 nucleic acid
#314METHODS AND COMPOSITIONS FOR DETECTING THE ACTIVATION STATE OF MULTIPLE PROTEINS IN SINGLE CELLS
#315Biomarkers for predicting the sensitivity and response of protein kinase CK2-mediated diseases to CK2 Inhibitors
#316IDENTIFICATION OF PREDICTIVE MARKERS OF RESPONSE TO DASATINIB IN HUMAN COLON CANCER
#317Methods and products relating to GSK3β regulation
#318Methods of chemotype evolution
#319Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the same
#320Anti-c-Met antibody
#321Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#322Methods and compositions for detecting the activation state of multiple proteins in single cells
#323Treatment of Cancers Expressing p95 ErbB2
#324Molecular profiling of tumors
#325Diagnosis method and treatment for cancer using liv21 proteins and E2F1/E2F4 biomarkers
#326Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
#327Modulating latency and reactivation of
#328Imidazopyrazine Syk inhibitors
#329Cancer Classification and Methods of Use
#330MULTIPLE MECHANISMS FOR MODULATION OF JAK/STAT ACTIVITY
#331COMPOSITIONS INCLUDING TRICIRIBINE AND ONE OR MORE PLATINUM COMPOUNDS AND METHODS OF USE THEREOF
#332Biomarkers for chronic vascular dysfunction
#333Methods and compositions for modulating synapse formation
#334COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID
#335Anti-phospho-Akt antibodies
#336METHODS AND COMPOSITIONS FOR INHIBITION OF AXONAL DEGENERATION BY MODULATION OF THE DLK/JNK PATHWAY
#337ACTIVATED HER3 AS A MARKER FOR PREDICTING THERAPEUTIC EFFICACY
#338EPHA2 receptor antagonist antibodies
#339METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES
#340Circulating tumor cell assay
#341Sparc and methods of use thereof
#342Calcium/Calmodulin-Dependent Protein Kinase Kinase as a Control Point for Cardiac Hypertrophy
#343Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)
#344Compositions and Methods for Treating Polyglutamine-Expansion Neurodegenerative Diseases
#345COMPOSITIONS AND METHODS FOR INHIBITING GSK3 ACTIVITY AND USES THEREOF
#346Rage/Diaphanous Interaction and Related Compositions and Methods
#347Treatment of cancers expressing p95 ErbB2
#348IDENTIFICATION OF NOVEL PATHWAYS FOR DRUG DEVELOPMENT FOR LUNG DISEASE
#349Determination of sFlt-1:angiogenic factor complex
#350Assay buffer, compositions containing the same, and methods of using the same
#351Identification of thymically derived CD4 T cells by protein tyrosine kinase 7 expression
#352Luminescence-based composition
#353METHOD FOR DETERMINING RISK OF CANCER RELAPSE AND COMPUTER PROGRAM PRODUCT
#354Modular point-of-care devices, systems, and uses thereof
#355METHODS OF TREATING BONE DISORDERS WITH MODULATORS OF AXL
#356Activin-actriia antagonists and uses for treating or preventing breast cancer
#357Novel Therapeutic Molecular Variants And Uses Thereof
#358METHODS AND KITS FOR DETECTING PROSTATE CANCER BIOMARKERS
#359Methods and marker combinations for screening for predisposition to lung cancer
#360Novel Use of the Kinases Rsk4 and Pak5
#361System and method for determining individualized medical intervention for a disease state
#362PROTEIN KINASE REGULATION
#363IRAK 1c splice variant and its use
#364METHODS OF SCREENING FOR ANTITUMOR AGENTS
#365Kit for detecting and measuring element tagged kinases and phosphatases by inductively coupled plasma mass spectrometry
#366Biomarkers in cancer
#367Crystal structure of human Pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
#368Cyclin groove inhibitors
#369Phosphokinase assay
#370Treatment of cancers expressing p95 erbb2
#371Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins
#372Enzyme assay with nanowire sensor
#373Methods and compositions for detecting the activation state of multiple proteins in single cells
#374Dynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
#375Method to modulate the immune system with a novel guanine nucleotide exchange factor
#376Tumour markers and biological applications thereof
#377Assay buffer, compositions containing the same, and methods of using the same
#378Assay buffer, compositions containing the same, and methods of using the same
#379Determining kinase specificity
#380Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation